Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.

The Prostate - 1 Mar 2005

Roberts Rosebud O, Bergstralh Erik J, Farmer Sara A, Jacobson Debra J, McGree Michaela E, Hebbring Scott J, Cunningham Julie M, Anderson Sarah A, Thibodeau Stephen N, Lieber Michael M, Jacobsen Steven J

Abstract excerpt

BACKGROUND: The objective of the study was to examine associations between SRD5A2 polymorphisms and measures of benign prostatic hyperplasia (BPH). METHODS: Participants were 510 Caucasian men (median age 60 years), randomly selected from the Olmsted County, MN community to participate in a longitudinal study of BPH. From 1990 through 2000, biennial measurements of lower urinary tract symptom severity (assessed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Aging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to 3-Oxo-5-alpha-Steroid 4-Dehydrogenase

Share to Longitudinal Studies

Share to Polymorphism, Genetic

Share to Prostatic Hyperplasia

Share to Severity of Illness Index

Source

Identifiers

PMID: 15389785
DOI: 10.1002/pros.20142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.PMID 15389785Read ↗

SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer.Semantic proximity Read ↗

Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.Semantic proximity Read ↗

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.Semantic proximity Read ↗

Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.Semantic proximity Read ↗

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.Semantic proximity Read ↗

Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Semantic proximity Read ↗

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.Semantic proximity Read ↗

SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample.Semantic proximity Read ↗

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.Semantic proximity Read ↗

Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.